Figure 3. Forest plot showing the effect of rhG-CSF on miscarriage rates in women with reproductive failure. No significant reduction in MR was observed with rhG-CSF compared with placebo, either among RPL patients (OR: 0.57; 95% CI, 0.17-1.84; I²=69%) or RIF patients (OR: 0.93; 95% CI, 0.17-5.16; I²=67%). The overall pooled effect was not statistically significant (OR: 0.72; 95% CI, 0.26-1.96; p=0.52; I²=68%).